Target intelligence / Profile preview

Lipid peroxidation in cellular and mitochondrial membranes (LPO)

Target
LPO
Molecular classification
Biological membrane, Lipid bilayer, Non-protein target
01

Overview

Cellular and mitochondrial membranes are the primary structural sites for lipid peroxidation, a self-propagating free radical chain reaction that degrades polyunsaturated fatty acids (PUFAs). This process is initiated by reactive oxygen species (ROS) and results in the formation of lipid hydroperoxides and reactive aldehydes, such as 4-hydroxynonenal (4-HNE), which can damage proteins and DNA (Ayala et al., 2014, Oxidative Medicine and Cellular Longevity). Mitochondrial membranes are especially vulnerable due to their high concentration of cardiolipin and proximity to the electron transport chain, a major source of endogenous ROS (Murphy, 2009, Biochemical Journal). Excessive lipid peroxidation is the hallmark of ferroptosis, a regulated form of iron-dependent cell death implicated in various pathologies including neurodegeneration and acute organ failure (Dixon et al., 2012, Cell). Therapeutic strategies target this process using lipophilic radical-trapping antioxidants (RTAs) like Ferrostatin-1 or mitochondria-targeted compounds like MitoQ to prevent membrane rupture and maintain cellular homeostasis (Gaschler & Stockwell, 2017, Nature Chemical Biology). Consequently, inhibiting lipid peroxidation is a major focus in developing treatments for diseases characterized by high oxidative stress and membrane dysfunction.

Other names
Membrane lipid peroxidationMitochondrial lipid peroxidationOxidative lipid degradationPUFA peroxidation chain reactionLipid peroxidation
02

Mechanism of action

Radical scavenging and chain-breaking inhibition of lipid hydroperoxide formation within the lipid bilayer

03

Biological functions

Membrane integrity maintenanceFerroptosis regulationOxidative stress responseSignal transductionCell death
04

Disease associations

Neurodegenerative diseaseIschemia-reperfusion injuryAtherosclerosisCancerAging-related pathologiesNonalcoholic steatohepatitis (NASH)
05

Safety considerations

Disruption of physiological redox signalingPotential pro-oxidant effects at high concentrationsAlteration of membrane fluidity and structural integrityPoor bioavailability and metabolic stability of lipophilic antioxidants
06

Interacting drugs

Alpha-tocopherol (Vitamin E)

8 more in the full profile.

07

Biomarkers

Malondialdehyde (MDA)4-Hydroxynonenal (4-HNE)F2-isoprostanesC11-BODIPY 581/591 oxidationLipid hydroperoxides (LOOH)

Beyond the preview

Go deeper on Lipid peroxidation in cellular and mitochondrial membranes (LPO).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lipid peroxidation in cellular and mitochondrial membranes (LPO).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call